Bank of Nova Scotia’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.63M | Sell |
26,814
-38,509
| -59% | -$11.8M | 0.01% | 488 |
|
|
2026
Q1 | $16.4M | Buy |
65,323
+50,402
| +338% | +$12.5M | 0.03% | 331 |
|
|
2025
Q4 | $4.11M | Sell |
14,921
-7,228
| -33% | -$1.98M | 0.01% | 674 |
|
|
2025
Q3 | $5.81M | Buy |
22,149
+12,506
| +130% | +$3.04M | 0.01% | 523 |
|
|
2025
Q2 | $2.11M | Sell |
9,643
-8,917
| -48% | -$1.91M | ﹤0.01% | 675 |
|
|
2025
Q1 | $4.16M | Sell |
18,560
-51,740
| -74% | -$14.3M | 0.01% | 495 |
|
|
2024
Q4 | $23M | Buy |
70,300
+61,004
| +656% | +$19.2M | 0.04% | 266 |
|
|
2024
Q3 | $2.79M | Buy |
9,296
+1,695
| +22% | +$519K | 0.01% | 585 |
|
|
2024
Q2 | $2.5M | Sell |
7,601
-1,583
| -17% | -$559K | ﹤0.01% | 596 |
|
|
2024
Q1 | $3.63M | Sell |
9,184
-10,871
| -54% | -$4.02M | 0.01% | 551 |
|
|
2023
Q4 | $7.06M | Sell |
20,055
-11,697
| -37% | -$4.14M | 0.01% | 462 |
|
|
2023
Q3 | $11.9M | Buy |
31,752
+25,704
| +425% | +$9.94M | 0.03% | 294 |
|
|
2023
Q2 | $2.31M | Buy |
6,048
+930
| +18% | +$332K | 0.01% | 501 |
|
|
2023
Q1 | $1.77M | Sell |
5,118
-1,000
| -16% | -$292K | 0.01% | 571 |
|
|
2022
Q4 | $1.44M | Sell |
6,118
-32
| -0.5% | -$7.58K | ﹤0.01% | 730 |
|
|
2022
Q3 | $1.51M | Sell |
6,150
-8,350
| -58% | -$2.54M | ﹤0.01% | 711 |
|
|
2022
Q2 | $4.36M | Buy |
14,500
+4,778
| +49% | +$1.55M | 0.01% | 515 |
|
|
2022
Q1 | $3.99M | Sell |
9,722
-28,485
| -75% | -$11.2M | 0.01% | 643 |
|
|
2021
Q4 | $17.9M | Buy |
38,207
+5,135
| +16% | +$2.21M | 0.03% | 403 |
|
|
2021
Q3 | $14M | Buy |
33,072
+6,724
| +26% | +$2.83M | 0.02% | 415 |
|
|
2021
Q2 | $9.46M | Buy |
26,348
+1,151
| +5% | +$380K | 0.02% | 459 |
|
|
2021
Q1 | $7.1M | Sell |
25,197
-20,137
| -44% | -$5.76M | 0.01% | 496 |
|
|
2020
Q4 | $12.8M | Buy |
45,334
+6,939
| +18% | +$1.95M | 0.03% | 338 |
|
|
2020
Q3 | $10.6M | Sell |
38,395
-30,508
| -44% | -$8.07M | 0.03% | 351 |
|
|
2020
Q2 | $15.7M | Buy |
68,903
+30,401
| +79% | +$5.97M | 0.05% | 239 |
|
|
2020
Q1 | $5.86M | Buy |
+38,502
| New | +$5.93M | 0.02% | 393 |
|
|
2019
Q4 | – | Sell |
-13,912
| Closed | -$1.97M | – | 995 |
|
|
2019
Q3 | $1.97M | Buy |
+13,912
| New | +$1.92M | 0.01% | 670 |
|
|
2019
Q1 | – | Sell |
-43,000
| Closed | -$4.21M | – | 935 |
|
|
2018
Q4 | $4.21M | Buy |
43,000
+2
| +0% | +$217 | 0.02% | 441 |
|
|
2018
Q3 | $5.31M | Buy |
+42,998
| New | +$4.82M | 0.02% | 421 |
|
Other funds holding WST
GIM
Bank of Nova Scotia's WST Position: Q2 2026 in Review
Bank of Nova Scotia reduced its West Pharmaceutical (WST) stake by 59% in Q2 2026, selling an estimated $11.8M and leaving 26,814 shares worth $9.63M. The position accounts for 0.01% of the portfolio, ranked #488.
Bank of Nova Scotia first reported a position in WST in Q3 2018 and has held it in 29 quarters since. The position peaked at $23M in Q4 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Bank of Nova Scotia held 26,814 shares of West Pharmaceutical worth $9.63M as of Q2 2026.
- Bank of Nova Scotia sold 38,509 West Pharmaceutical shares in Q2 2026, an estimated $11.8M.
- West Pharmaceutical made up 0.01% of Bank of Nova Scotia's portfolio in Q2 2026, its #488 holding.
- Bank of Nova Scotia first reported a position in West Pharmaceutical in Q3 2018 and has held it in 29 quarters since.
- Bank of Nova Scotia's West Pharmaceutical position peaked at $23M in Q4 2024.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.